WA-AMAZON.COM
Amazon (NASDAQ: AMZN) today announced The Lord of the Rings: The Rings of Power attracted more than 25 million global viewers on its first day, breaking all previous records, marking the biggest premiere in the history of Prime Video. The series launched exclusively on Prime Video in more than 240 countries and territories worldwide.
Jennifer Salke, head of Amazon Studios, said: “It is somehow fitting that Tolkien’s stories - among the most popular of all time, and what many consider to be the true origin of the fantasy genre - have led us to this proud moment. I am so grateful to the Tolkien Estate – and to our showrunners J.D. Payne and Patrick McKay, executive producer Lindsey Weber, cast and crew - for their tireless collaborative efforts and boundless creative energy. And it is the tens of millions of fans watching – clearly as passionate about Middle-earth as we are – who are our true measure of success.”
Episodes of The Lord of the Rings: The Rings of Power will launch weekly through the October 14 season finale on Prime Video.
About The Lord of the Rings: The Rings of Power
Prime Video’s The Lord of the Rings: The Rings of Power brings to screens for the very first time the heroic legends of the fabled Second Age of Middle-earth's history. This epic drama is set thousands of years before the events of J.R.R. Tolkien’s The Hobbit and The Lord of the Rings, and will take viewers back to an era in which great powers were forged, kingdoms rose to glory and fell to ruin, unlikely heroes were tested, hope hung by the finest of threads, and one of the greatest villains that ever flowed from Tolkien’s pen threatened to cover all the world in darkness. Beginning in a time of relative peace, the series follows an ensemble cast of characters, both familiar and new, as they confront the long-feared reemergence of evil to Middle-earth. From the darkest depths of the Misty Mountains, to the majestic forests of the elf-capital of Lindon, to the breathtaking island kingdom of Númenor, to the farthest reaches of the map, these kingdoms and characters will carve out legacies that live on long after they are gone.
The series is led by showrunners and executive producers J.D. Payne & Patrick McKay. They are joined by executive producers Lindsey Weber, Callum Greene, J.A. Bayona, Belén Atienza, Justin Doble, Jason Cahill, Gennifer Hutchison, Bruce Richmond, and Sharon Tal Yguado, and producers Ron Ames and Christopher Newman. Wayne Che Yip is co-executive producer and directs along with J.A. Bayona and Charlotte Brändström.
A world-renowned literary work, and winner of the International Fantasy Award and Prometheus Hall of Fame Award, The Lord of the Rings was named Amazon customers’ favorite book of the millennium in 1999 and Britain’s best-loved novel of all time in BBC’s "The Big Read" in 2003. The Lord of the Rings books have been translated into over 38 languages and have sold more than 150 million copies.
Please visit https://press.amazonstudios.com/us/en/original-series/the-lord-of-the-rings-amazon-original-series/1 for additional information.
About Amazon
Amazon is guided by four principles: customer obsession rather than competitor focus, passion for invention, commitment to operational excellence, and long-term thinking. Customer reviews, 1-Click shopping, personalized recommendations, Prime, Fulfillment by Amazon, AWS, Kindle Direct Publishing, Kindle, Fire tablets, Fire TV, Amazon Echo, and Alexa are some of the products and services pioneered by Amazon. For more information, visit amazon.com/about and follow @AmazonNews.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220903005024/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Mandate of BaFin’s special commissioner at flatexDEGIRO terminated18.10.2024 17:25:00 CEST | Press release
Mandate of BaFin’s special commissioner at flatexDEGIRO terminated The mandate of the BaFin’s special commissioner at flatexDEGIRO Bank AG (the “Company”) was terminated on September 30, 2024, following the successful elimination of the serious deficiencies identified in the 2022 special audit by the Company and a positive review by the special commissioner. flatexDEGIRO AG made this announcement on October 18, 2024, following a corresponding decision by the German Federal Financial Supervisory Authority (BaFin). Oliver Behrens, CEO of flatexDEGIRO, said: “We have realigned and sustainably strengthened our organizational structures and processes in constructive cooperation with BaFin and the special commissioner. We are thereby closing a regulatory chapter and again increase our focus on our customers and important growth projects. My special thanks go to all employees who, under the leadership of Steffen Jentsch, member of the bank's management board, have made it possible to reach th
Biological Lattice Industries (BLI) Secures $1.8 Million Pre-Seed Funding Led by Uni.Fund to Democratize Biofabrication18.10.2024 16:00:00 CEST | Press release
Biological Lattice Industries Corp. (BLI), a leading innovator in biofabrication and life sciences R&D, today announced the successful closing of a $1.8 million pre-seed investment round led by Greek venture capital firm Uni.Fund. In conjunction with this funding announcement , BLI is introducing its first all-in-one solution for biofabrication: BioLoom™, BLI's advanced multi-tool 3D bioprinter and Loominus Studio™, its unified software platform designed to revolutionize biofabrication workflows. BLI, a US startup with R&D operations in Greece, aims to radically simplify biofabrication for the global R&D community by providing intelligent, automated tools that streamline the design, fabrication, and testing of biomaterials. Biomaterials are critical for a wide array of biological applications. The applications range from advanced 3D cell culture systems for human biology emulation to the next-generation of resorbable medical devices and drug delivery systems for tissue trauma repair. “
Gurobi Brings Decision Intelligence Summit to Amsterdam18.10.2024 15:00:00 CEST | Press release
The event will unite industry leaders from across the EMEAI region for two days of in-person learning and networking. Gurobi Optimization, LLC, the leader in decision intelligence technology, is set to host the first annual EMEAI Decision Intelligence Summit (“Gurobi Summit”) at Amsterdam’s Capital C on November 5-6, 2024. Following the success of last month’s inaugural summit for the Americas in Las Vegas, the EMEAI Summit will bring together operations researchers, data scientists, and business leaders from across the region to explore the latest advancements in mathematical optimization and decision intelligence. The Gurobi Summit will feature special presentations from companies such as Accenture and ICRON. Several of the company’s partners—including Decide4AI, Decision Labs, LTPLabs, and ORMAE—will also be present to showcase their solutions and insights. The two-day event will be packed with informative presentations, exciting customer case studies, and interactive learning oppor
Vertex to Present Phase 3 Data Highlighting Suzetrigine’s Potential as a First-in-Class, Highly Selective Pain Signal Inhibitor at the American Society of Anesthesiologists Annual Meeting18.10.2024 14:00:00 CEST | Press release
-- Phase 3 abstract selected for presentation in “Best Abstract” session -- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the company will present its pivotal Phase 3 data on suzetrigine, an investigational, oral, highly selective NaV1.8 pain signal inhibitor for the treatment of moderate-to-severe acute pain, at the annual meeting of the American Society of Anesthesiologists (ASA), taking place from October 18-22, 2024 in Philadelphia, Pennsylvania. Abstract A1187 — “Randomized, Placebo-Controlled, Phase 3 Trials of Suzetrigine, a Non-Opioid, Pain Signal Inhibitor for Treatment of Acute Pain After Abdominoplasty or Bunionectomy” will be presented as an oral presentation on Sunday, October 20, during the “Best Abstract” session, which runs from 8:00-11:00 a.m. ET, as well as the Education session which runs on Monday, October 21, from 1:30-2:30 p.m. ET. Abstract A2074 — “A Phase 3, Single-Arm Study of Suzetrigine, a Non-Opioid, Pain Signal Inhibitor For Treatm
MDPI Champions Open Access for Global Progress18.10.2024 10:00:00 CEST | Press release
During International Open Access Week 2024, MPDI promotes open scholarship to accelerate scientific discovery and advance social outcomes MDPI, a leading open access (OA) publisher, is proud to announce its participation in International Open Access Week 2024, 21–27 October. This year’s theme, “Community over Commercialization”, resonates with MDPI’s commitment to publishing insights for everyone, regardless of background. OA Week is a valuable opportunity to inspire engagement with the open access movement and to advocate for more sustainable and inclusive scholarly communication. This mission, shared by MDPI, helps to ensure that all communities have the means to participate in shaping global futures. To support these aims, MDPI will be sharing a variety of digital resources discussing quality and ethics in OA publishing, the tools we provide to support researchers, and the benefits of OA and open research. For more information on MDPI’s initiatives, please visit our website. By work
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom